New Delhi: HUL”s consolidated net profit was Rs 1,631 crore in the October-December quarter previous fiscal.
Its sales during the quarter increased 20.26 per cent to Rs 11,969 crore, as against Rs 9,953 crore a year ago, Hindustan Unilever Ltd (HUL) said in a regulatory filing.
However, on like to like basis, excluding the impact of the merger of GSK CH and acquisition of VWash, its sales growth was 7 per cent, HUL CFO Srinivas Phatak said while addressing a post earning call.
“Our comparable revenue growth is 7 per cent,” said Phatak, adding “it has two components. One is volume plus mix and another one is the price. Price growth is 3 per cent and volume plus mix, which is underlying volume growth (UVG) is 4 per cent”.
According to HUL, higher mobility, consumer-relevant innovations and investments behind market development are driving business momentum.
“We are very pleased with the performance, penetration and the volume share are going up nearly 86 of our business, which is remarkable for the company of our size and the multi-category in which we operate,” said HUL CMD Sanjiv Mehta.
Health, hygiene and nutrition segment formed 80 per cent of HUL’s portfolio and continues to grow in double digits with significant improvement in discretionary categories.
